AK Medical Holdings Limited (1789.HK)

6.050 -0.130 (-2.10%) At close: 04:08PM HKT

AK Medical Holdings Limited

Xingye Building
2nd Floor No. 10 Baifuquan Road Changping District Science & Tech Park
Beijing 102200
China
86 10 8010 9581
https://www.ak-medical.net

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 1,052

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Zhijiang Li	Chairman & CEO	1.05M	N/A	1968
Ms. Bin Mo Zhang	Senior VP & Executive Director	32.38k	N/A	1968
Mr. Chaoyang Zhang	Senior VP & Executive Director	1.17M	N/A	1969
Ms. Xiaohong Zhao	Executive Director	1.22M	N/A	1978
Ms. Kun Liang	Chief Financial Officer	N/A	N/A	1985
Mr. Hanzhong Sun	Vice President of Human Resources	N/A	N/A	1971
Ms. Yu Han	Company Secretary	N/A	N/A	1983

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in HKD.

Description

AK Medical Holdings Limited, an investment holding company, designs, develops, produces, and markets orthopedic joint implants and related products under the AK Medical brand in China and internationally. It offers knee, hip, and spinal and trauma replacement implants; and 3D-printed products, such as 3D-printed hip and knee replacement implants, 3D-printed spinal and trauma implants, and customised products and services. The company also distributes third party orthopedic products; and manufactures surgical instruments and medical irrigators. Its principal customers include distributors, hospitals, physicians and surgeons, and patients. The company was founded in 2003 and is headquartered in Beijing, the People's Republic of China. AK Medical Holdings Limited is a subsidiary of Ximalaya Limited.

Corporate governance

AK Medical Holdings Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.